autologous anti-CD83 CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-011410
A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD83, with potential antineoplastic activity. Upon administration, autologous anti-CD83 CAR T cells recognize and kill CD83-expressing tumor cells. CD83 is expressed on acute myeloid leukemia (AML) blasts.
| Identifier | MLC-T-ONC-011410 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous anti-CD83 CAR-T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011410",
"term": "autologous anti-CD83 CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD83, with potential antineoplastic activity. Upon administration, autologous anti-CD83 CAR T cells recognize and kill CD83-expressing tumor cells. CD83 is expressed on acute myeloid leukemia (AML) blasts.",
"synonyms": [
"autologous anti-CD83 CAR-T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-cd83-car-t-cells/"
}
Record 2,742 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.